These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 38782386)

  • 21. Novel method for evaluating the indication for endoscopic papillectomy in patients with ampullary adenocarcinoma.
    Yamamoto K; Itoi T; Nagata N; Sofuni A; Tsuchiya T; Ishii K; Tanaka R; Tonozuka R; Honjo M; Mukai S; Asai Y; Matsunami Y; Yamaguchi H; Matsubayashi J; Joyama E; Nagakawa Y
    Sci Rep; 2021 Jan; 11(1):600. PubMed ID: 33436750
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Oncologic outcomes in resected ampullary cancer: Relevance of histologic subtype and adjuvant chemotherapy.
    Affi Koprowski M; Sutton TL; Brinkerhoff BT; Grossberg A; Sheppard BC; Mayo SC
    Am J Surg; 2021 Jun; 221(6):1128-1134. PubMed ID: 33883071
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Predictors of long-term survival following resection for ampullary carcinoma: a large retrospective French multicentric study.
    Robert PE; Leux C; Ouaissi M; Miguet M; Paye F; Merdrignac A; Delpero JR; Schwarz L; Carrere N; Muscari F; Gayet B; Dussart D; Hamy A; Regenet N
    Pancreas; 2014 Jul; 43(5):692-7. PubMed ID: 24713843
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Phenotypic characterization and clinical outcome in ampullary adenocarcinoma.
    Asano E; Okano K; Oshima M; Kagawa S; Kushida Y; Munekage M; Hanazaki K; Watanabe J; Takada Y; Ikemoto T; Shimada M; Suzuki Y;
    J Surg Oncol; 2016 Jul; 114(1):119-27. PubMed ID: 27132476
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The use of histopathological subtyping in patients with ampullary cancer: a nationwide analysis.
    de Bakker J; Sommeijer D; Besselink M; Kazemier G; van Grieken N
    World J Surg Oncol; 2022 Dec; 20(1):406. PubMed ID: 36566267
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Ampullary region carcinomas: definition and site specific classification with delineation of four clinicopathologically and prognostically distinct subsets in an analysis of 249 cases.
    Adsay V; Ohike N; Tajiri T; Kim GE; Krasinskas A; Balci S; Bagci P; Basturk O; Bandyopadhyay S; Jang KT; Kooby DA; Maithel SK; Sarmiento J; Staley CA; Gonzalez RS; Kong SY; Goodman M
    Am J Surg Pathol; 2012 Nov; 36(11):1592-608. PubMed ID: 23026934
    [TBL] [Abstract][Full Text] [Related]  

  • 27. 15-year experience with surgical treatment of duodenal carcinoma: a comparison of periampullary and extra-ampullary duodenal carcinomas.
    Onkendi EO; Boostrom SY; Sarr MG; Farnell MB; Nagorney DM; Donohue JH; Kendrick ML; Reid-Lombardo KM; Harmsen WS; Que FG
    J Gastrointest Surg; 2012 Apr; 16(4):682-91. PubMed ID: 22350721
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Ampullary carcinoma is often of mixed or hybrid histologic type: an analysis of reproducibility and clinical relevance of classification as pancreatobiliary versus intestinal in 232 cases.
    Reid MD; Balci S; Ohike N; Xue Y; Kim GE; Tajiri T; Memis B; Coban I; Dolgun A; Krasinskas AM; Basturk O; Kooby DA; Sarmiento JM; Maithel SK; El-Rayes BF; Adsay V
    Mod Pathol; 2016 Dec; 29(12):1575-1585. PubMed ID: 27586202
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pathological factors influencing survival of carcinoma of the ampulla of Vater.
    Mori K; Ikei S; Yamane T; Yamaguchi Y; Katsumori T; Shibata Y; Arai T
    Eur J Surg Oncol; 1990 Jun; 16(3):183-8. PubMed ID: 2347413
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Significance analysis of histologic type and perineural invasion as prognostic factors after curative resection of ampulla of Vater carcinoma.
    Lee JH; Lee KG; Ryou H; Jun YJ; Paik SS; Park HK; Lee KS
    Hepatogastroenterology; 2010; 57(99-100):646-52. PubMed ID: 20698243
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Combined application of immunohistochemical markers to identify pathologic subtypes of ampullary carcinoma and its clinical significance].
    Liu FF; Shen DH; Wang HL; Ma YT; Yuan F; Liu J; Chen L; Song QJ; Zhang YY
    Zhonghua Bing Li Xue Za Zhi; 2019 Feb; 48(2):92-97. PubMed ID: 30695858
    [No Abstract]   [Full Text] [Related]  

  • 32. Intra-ampullary papillary-tubular neoplasm (IAPN): characterization of tumoral intraepithelial neoplasia occurring within the ampulla: a clinicopathologic analysis of 82 cases.
    Ohike N; Kim GE; Tajiri T; Krasinskas A; Basturk O; Coban I; Bandyopadhyay S; Morohoshi T; Goodman M; Kooby DA; Sarmiento JM; Adsay NV
    Am J Surg Pathol; 2010 Dec; 34(12):1731-48. PubMed ID: 21084962
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Histopathologic Predictors of Survival and Recurrence in Resected Ampullary Adenocarcinoma: International Multicenter Cohort Study.
    Moekotte AL; Lof S; Van Roessel S; Fontana M; Dreyer S; Shablak A; Casciani F; Mavroeidis VK; Robinson S; Khalil K; Gradinariu G; Mowbray N; Al-Sarireh B; Fusai GK; Roberts K; White S; Soonawalla Z; Jamieson NB; Salvia R; Besselink MG; Abu Hilal M
    Ann Surg; 2020 Dec; 272(6):1086-1093. PubMed ID: 30628913
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Impact of circumferential resection margin on survival in ampullary cancer: retrospective analysis.
    Nießen A; Loos M; Neumüller K; Feißt M; Klaiber U; Cizmic A; Al-Saeedi M; Roth S; Schneider M; Büchler MW; Hackert T
    BJS Open; 2023 Nov; 7(6):. PubMed ID: 38155394
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Concurrent MET copy number gain and KRAS mutation is a poor prognostic factor in pancreatobiliary subtype ampullary cancers.
    Kwon MJ; Kim JW; Jeon JY; Nam ES; Cho SJ; Park HR; Min SK; Seo J; Min KW; Choe JY; Lee HK
    Pathol Res Pract; 2017 Apr; 213(4):381-388. PubMed ID: 28214200
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prognostic Factors of Long-term Survival Following Radical Resection for Ampullary Carcinoma.
    Vilhordo DW; Gregório C; Valentini DF; Edelweiss MIA; Uchoa DM; Osvaldt AB
    J Gastrointest Cancer; 2021 Sep; 52(3):872-881. PubMed ID: 32808236
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Low incidence of KRAS, BRAF, and PIK3CA mutations in adenocarcinomas of the ampulla of Vater and their prognostic value.
    Kwon MJ; Kim JW; Jung JP; Cho JW; Nam ES; Cho SJ; Kim JS; Park HR; Min SK; Seo J; Min KW; Kim DH; Jeon JY
    Hum Pathol; 2016 Apr; 50():90-100. PubMed ID: 26997442
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Treatment utilization and surgical outcome of ampullary and duodenal adenocarcinoma.
    Shaib WL; Sharma R; Brutcher E; Kim S; Maithel SK; Chen Z; Kooby DA; Kauh J; Landry J; El-Rayes BF
    J Surg Oncol; 2014 May; 109(6):556-60. PubMed ID: 24338561
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prognostic impact of perineural invasion following pancreatoduodenectomy with lymphadenectomy for ampullary carcinoma.
    Sudo T; Murakami Y; Uemura K; Hayashidani Y; Hashimoto Y; Ohge H; Shimamoto F; Sueda T
    Dig Dis Sci; 2008 Aug; 53(8):2281-6. PubMed ID: 18095164
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Performance and prognostic utility of the 92-gene assay in the molecular subclassification of ampullary adenocarcinoma.
    Overman MJ; Soifer HS; Schueneman AJ; Ensor J; Adsay V; Saka B; Neishaboori N; Wolff RA; Wang H; Schnabel CA; Varadhachary G
    BMC Cancer; 2016 Aug; 16(1):668. PubMed ID: 27549176
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.